In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450

Toxicology in Vitro

Volumn 25, Issue 4, 2011, Pages 890-896

  Winitthana, T ^a   Niwattisaiwong, N ^a   Patarapanich, C ^a   Tantisira, M H ^a   Lawanprasert, S ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Asiaticoside; Centella asiatica; Cytochrome P450; Drug interaction; Inhibition; Madecassoside

Indexed keywords

ASIATICOSIDE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; MADECASSOSIDE; PLANT GLYCOSIDE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; IC 50; IN VITRO STUDY;

CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; SOLUBILITY; TRITERPENES;

CENTELLA ASIATICA;

EID: 79955478202     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.02.010     Document Type: Article

References (19)

1. Barnes J., Anderson L.A., Phillipson J.D. Herbal Medicines a Guide for Health Care Professionals 2006, The Pharmaceutical Press, London, pp. 371-373.
2. Brass C., Galgiani J.N., Blaschke T.F., Defelice R., O'reilly R.A., Stevens D.A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob. Agents Chemother. 1982, 21:151-158.
3. Chen S.W., Wang W.J., Li W.J., Wang R., Li Y.L., Huang Y.N., Liang X. Anxiolytic-like effect of asiaticoside in mice. Pharmacol. Biochem. Behav. 2006, 85:339-344.
4. Coleman M.D. Human Drug Metabolism: An Introduction 2005, John Wiley & Sons Ltd., Chichester, England, pp. 75-95.
5. Dumrongsakunchai W., Attakornvattana V., Somanabandhu A., Vannaprasaht S., Tassaneeyakul W., Tassaneeyakul W. Inhibitory effect and mechanism-based inhibition of Thai herbal plants on CYP3A4 and CYP2D6 activities. Thai J. Pharmacol. 2007, 29:35-39.
6. Gibson G.G., Skett P. Introduction to Drug Metabolism 2001, Nelson Thornes Publishers, Cheltenham, United Kingdom, pp. 87-116. third ed.
7. Guo J.S., Cheng C.L., Koo M.W. Inhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med. 2004, 70:1150-1154.
8. Hatorp V., Hansen K.T., Thomsen M.S. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide. J. Clin. Pharmacol. 2003, 43:649-660.
9. Huang Y.H., Zhang S.H., Zhen R.X., Xu X.D., Zhen Y.S. Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine. AiZheng. 2004, 23:1599-1604.
10. Jones D.R., Hall S.D. Mechanism-based inhibition of human cytochromes P450: in vitro kinetics and in vitr-in vivo correlations. Drug-drug Interactions 2002, 387-414. Marcel Dekker, Inc., New York. A.D. Rodrigues (Ed.).
11. Li G.G., Bian G.X., Ren J.P., Wen L.Q., Zhang M., Lü Q.J. Protective effect of madecassoside against reperfusion injury after regional ischemia in rabbit heart in vivo. Yao Xue Xue Bao. 2007, 42:475-480.
12. Liu M.R., Han T., Chen Y., Qin L.P., Zheng H.C., Rui Y.C. Effect of madecassoside on depression behavior of mice and activities of MAO in different brain regions of rats. Zhong Xi Yi Jie He Xue Bao. 2004, 2:440-444.
13. Liu M., Dai Y., Yao X., Li Y., Luo Y., Xia Y., Gong Z. Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice. Int. Immunopharmacol. 2008, 8:1561-1566.
14. A contemporary approach to screen for cytochrome P450 metabolism and inhibition using Vivid® fluorogenic substrates Available from: [online, 2008].
15. Marks, B.D., Larson, B.R., 2008. Miniaturization and automation of cytochrome P450 inhibition assays [online]. Available from: <> [2008, April 21]. http://www.tools.invitrogen.com/downloads/Miniaturization_Automation_CytochromeP450.pdf.
16. Obach R.S., Walsky R.L., Venkatakrishnan K. Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions. Drug Metab. Dispos. 2007, 35:246-255.
17. Tracy T.S. Enzyme kinetics. Drug Metabolism in Drug Design and Development 2008, 89-112. John Wiley & Sons, Inc., New Jersey. D. Zhang, M. Zhu, W.G. Humphreys (Eds.).
18. Zhang H., Sinz M.W., Rodrigues A.D. Metabolism-mediated drug-drug interactions. Drug Metabolism in Drug Design and Development 2008, 113-136. John Wiley & Sons, Inc., New Jersey. D. Zhang, M. Zhu, W.G. Humphreys (Eds.).
19. Zhang W., Ramamoorthy Y., Kilicarslan T., Nolte H., Tyndale R.F., Sellers E.M. Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab. Dispos. 2002, 30:314-318.